Exercise of options and total voting rights

AI SummaryClose X

Fusion Antibodies plc announced the exercise of options by an employee, resulting in the issuance of 135,000 new ordinary shares at an exercise price of 4.25p per share. These new shares are expected to be admitted to trading on AIM on or around June 8, 2026. Following this issuance, the Company's total number of ordinary shares in issue will be 125,156,878, with no shares held in treasury, which shareholders can use for notification calculations under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

UK 100

Latest directors dealings